AllianceBernstein
AGTC

AllianceBernstein’s Applied Genetic Technologies Corporation AGTC Stock Holding History

AllianceBernstein’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-84,700
Closed -$1.2M – 2994
2016
Q2 		$1.2M Buy
84,700
+71,880
+561% +$1.12M ﹤0.01% 2118
2016
Q1 		$179K Buy
+12,820
New +$188K ﹤0.01% 2740
2015
Q2 		– Sell
-2,600
Closed -$52K – 3333
2015
Q1 		$52K Buy
2,600
+1,800
+225% +$40.2K ﹤0.01% 3135
2014
Q4 		$17K Hold
800
– – ﹤0.01% 3250
2014
Q3 		$15K Sell
800
-800
-50% -$14.5K ﹤0.01% 3240
2014
Q2 		$37K Buy
+1,600
New +$28.2K ﹤0.01% 3154

Other funds holding AGTC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein's AGTC Position: Q3 2016 in Review

AllianceBernstein sold out of Applied Genetic Technologies Corporation (AGTC) in Q3 2016, closing a stake of 84,700 shares — an estimated $1.2M sold.

AllianceBernstein first reported a position in AGTC in Q2 2014 and held it in 6 quarters. The position peaked at $1.2M in Q2 2016. 95 funds tracked by Wall St. Rank hold AGTC as of Q3 2016.

  • AllianceBernstein reported no remaining Applied Genetic Technologies Corporation position as of Q3 2016 after selling out during the quarter.
  • AllianceBernstein sold 84,700 Applied Genetic Technologies Corporation shares in Q3 2016, an estimated $1.2M.
  • AllianceBernstein first reported a position in Applied Genetic Technologies Corporation in Q2 2014 and held it in 6 quarters.
  • AllianceBernstein's Applied Genetic Technologies Corporation position peaked at $1.2M in Q2 2016.
  • 95 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q3 2016.

Based on AllianceBernstein's 13F filing for Q3 2016, filed 10 Nov 2016.